Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Editorial

Moving toward hepatitis B virus functional cure - the impact of on-treatment kinetics of serum viral markers

Lilian Yan Liang, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Terry Cheuk-Fung Yip

Clin Mol Hepatol. 2023;29(1):113-117. Published online October 31, 2022

DOI: https://doi.org/10.3350/cmh.2022.0333

View: 3814 Download: 115 Web of Science: 3 Crossref: 4

Original Article

Serum fibrosis index-based risk score predicts hepatocellular carcinoma in untreated patients with chronic hepatitis B

Lilian Yan Liang, Hye Won Lee, Vincent Wai-Sun Wong, Terry Cheuk-Fung Yip, Yee-Kit Tse, Vicki Wing-Ki Hui, Grace Chung-Yan Lui, Henry Lik-Yuen Chan, Grace Lai-Hung Wong

Clin Mol Hepatol. 2021;27(3):499-509. Published online February 26, 2021

DOI: https://doi.org/10.3350/cmh.2020.0333

View: 5757 Download: 142 Web of Science: 16 Crossref: 16

Review

Unmet need in chronic hepatitis B management

Lilian Yan Liang, Grace Lai-Hung Wong

Clin Mol Hepatol. 2019;25(2):172-180. Published online February 12, 2019

DOI: https://doi.org/10.3350/cmh.2018.0106

View: 10362 Download: 403 Web of Science: 44 Crossref: 46

1 |

Viewed By 6567	MAFLD: How is it different from NAFLD?
Viewed By 5200	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 5057	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 3567	Gut microbiome and metabolome signatures in liver cirrhosis-related complications
Viewed By 3252	Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis

Cited By 287	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 244	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 161	MAFLD: How is it different from NAFLD?
Cited By 85	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 84	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search